Quebec’s Superior Court has granted leave to pursue a shareholder class action on behalf of purchasers of securities issued by Valeant Pharmaceuticals International Inc. who acquired them between Feb. 2013 and Oct. 2015.
Leave has been granted based on allegations that Valeant’s filings with securities regulators in Canada and the United States contained materially false or misleading statements.
The Court’s decision allows the plaintiffs to advance their action as a class proceeding which will now proceed toward trial.
The class action plaintiffs are represented by various Canadian law firms, including Investigation Counsel PC, Siskinds LLP, and Faguy & Co.
Read more at Newswire
